Viking Therapeutics Receives $24,000,000 New Financing

  • Feed Type
  • Date
    4/29/2015
  • Company Name
    Viking Therapeutics
  • Mailing Address
    11119 North Torrey Pines Road La Jolla, CA 92037 USA
  • Company Description
    Viking Therapeutics (NASDAQ: VKTX) is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.
  • Website
    http://www.vikingtherapeutics.com
  • Transaction Type
    IPO
  • Transaction Amount
    $24,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy